Compare Suncare Traders with Similar Stocks
Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -7.25% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -1.14
Negative results in Mar 26
Risky - Negative EBITDA
Stock DNA
Trading & Distributors
INR 12 Cr (Micro Cap)
19.00
21
0.00%
0.14
1.61%
0.30
Total Returns (Price + Dividend) 
Suncare Traders for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Suncare Traders Ltd Falls to 52-Week Low of Rs 0.4 as Sell-Off Deepens
For the second consecutive session, Suncare Traders Ltd has succumbed to selling pressure, sliding to a fresh 52-week low of Rs 0.4 on 30 Jun 2026. This decline extends the stock’s year-long underperformance, with a steep 62.73% drop compared to the Sensex’s relatively modest 8.3% fall over the same period.
Read full news article
Suncare Traders Ltd Falls to 52-Week Low of Rs 0.41 as Sell-Off Deepens
For the fifth consecutive session, Suncare Traders Ltd closed lower, hitting a fresh 52-week low of Rs 0.41 on 24 Jun 2026. This decline comes amid a broader market rally, with the Sensex gaining 1.09% and reaching 77,032.13, underscoring a stark divergence between the stock and the benchmark index.
Read full news article Announcements 
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
24-Jun-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Shree Ganesh Bio Tech (India) Ltd
Closure of Trading Window
11-Jun-2026 | Source : BSEPFA
Compliances-Reg.24(A)-Annual Secretarial Compliance
21-May-2026 | Source : BSEPFA
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
Suncare Traders Ltd has announced 2:10 stock split, ex-date: 06 Mar 20
Suncare Traders Ltd has announced 2:1 bonus issue, ex-date: 06 Mar 20
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 0 FIIs
Biogen Pharmachem Industries Limited (4.29%)
Nilmesh Infrabuild Llp (11.78%)
66.02%
Quarterly Results Snapshot (Standalone) - Mar'26 - YoY
YoY Growth in quarter ended Mar 2026 is 0.00% vs -100.00% in Mar 2025
YoY Growth in quarter ended Mar 2026 is -560.00% vs -121.05% in Mar 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 0.00% vs 0.00% in Sep 2024
Growth in half year ended Sep 2025 is -633.33% vs 108.33% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 0.00% vs -100.00% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -84.81% vs 241.07% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 0.00% vs -100.00% in Mar 2025
YoY Growth in year ended Mar 2026 is 11.86% vs 51.28% in Mar 2025







